|
U.S. FDA Seeks Postapproval Hip Implant Studies
The U.S. Food and Drug Administration (FDA) is asking 21 devicemakers to conduct postapproval studies for their metal-on-metal (MoM) hip implants after reports of high ion concentrations of cobalt and chromium in the blood of patients using the devices.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives